Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bifidobacterium-based Probiotics in Reducing Blood Pressure in Middle-aged Chinese With Hypertension
NCT07206303Phase 1Not yet recruiting
- Sponsor
- The University of Hong Kong
- Start
- Nov 2026
- Primary completion
- Nov 2027
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial in hypertension (HTN), sponsored by The University of Hong Kong. Primary endpoint: Mean seated clinic systolic blood pressure at Week 12. Planned start Nov 2026; status: not yet recruiting.
02
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT07206303.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07206303.